Menu
 
Research menu
Jump to menu

Publications:  Sharmilee Gnanapavan

Gnanapavan S, Giovannoni G (2015) . Developing Biomarkers for MS.Curr Top Behav Neurosci vol. 26, 179-194.
10.1007/7854_2014_362
http://qmro.qmul.ac.uk/xmlui/handle/123456789/6325
Gnanapavan S, Yousaf N, Heywood W et al. (2014) . Growth associated protein (GAP-43): cloning and the development of a sensitive ELISA for neurological disorders.J Neuroimmunol vol. 276, (1-2) 18-23.
10.1016/j.jneuroim.2014.07.008
Cooper R, Doshi A, Harris P et al. (2014) . IMMUNOCOMPETENT PML¿AN IMMUNOLOGICAL SCOTOMA?. Journal of Neurology, Neurosurgery & Psychiatry. vol. 85, e4.16-e4.
10.1136/jnnp-2014-309236.112
Gnanapavan S, Hegen H, Khalil M et al. (2014) . Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders.Neurology vol. 83, (13) 1210-1216.
10.1212/WNL.0000000000000809
Amor S, van der Star BJ, Bosca I et al. (2014) . Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.Mult Scler vol. 20, (10) 1355-1362.
10.1177/1352458514521887
Gnanapavan S, Sillery E, Acheson JF et al. (2014) . Parinaud's syndrome ¿ A rare presentation of clinically isolated syndrome.Multiple Sclerosis and Related Disorders vol. 3, (3) 398-401.
10.1016/j.msard.2013.09.003
Gnanapavan S, Jaunmuktane Z, Baruteau KP et al. (2014) . A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.BMC Neurol vol. 14,
10.1186/1471-2377-14-68
http://qmro.qmul.ac.uk/xmlui/handle/123456789/7244
Teunissen C, Menge T, Altintas A et al. (2013) . Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.Mult Scler vol. 19, (13) 1802-1809.
10.1177/1352458513488232
Dobson R, McMillan A, Kung K et al. (2013) . Think outside the box, collapse the box, and take a sharp knife to it!.J Neurol Neurosurg Psychiatry vol. 84, (11)
10.1136/jnnp-2013-306573.173
Gnanapavan S, Grant D, Morant S et al. (2013) . Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression.PLOS ONE vol. 8, (8) Article ARTN e70019,
10.1371/journal.pone.0070019
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11260
Gnanapavan S, Ho P, Heywood W et al. (2013) . Progression in multiple sclerosis is associated with low endogenous NCAM.J Neurochem vol. 125, (5) 766-773.
10.1111/jnc.12236
Lax NZ, Gnanapavan S, Dowson SJ et al. (2013) . Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.J Neuropathol Exp Neurol vol. 72, (2) 164-175.
10.1097/NEN.0b013e31828129c5
Gnanapavan S, Giovannoni G (2013) . Neural cell adhesion molecules in brain plasticity and disease.Multiple Sclerosis and Related Disorders vol. 2, (1) 13-20.
10.1016/j.msard.2012.08.002
Gnanapavan S, Grant D, Pryce G et al. (2012) . Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis.Autoimmunity vol. 45, (4) 298-303.
10.3109/08916934.2012.654865
Jia Y, Wu T, Jelinek CA et al. (2012) . Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).Clin Proteomics vol. 9, (1)
10.1186/1559-0275-9-9
Gnanapavan S, Vincent A, Giovannoni G (2011) . Surviving stiff-person syndrome: a case report.J NEUROL vol. 258, (10) 1898-1900.
10.1007/s00415-011-6015-z
Gnanapavan S, Grant D, Illes-Toth E et al. (2010) . Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders.J Neuroimmunol vol. 225, (1-2) 118-122.
10.1016/j.jneuroim.2010.04.020
Gnanapavan S, Jackson S, Grant D et al. (2008) . Neural cell adhesion molecule as a biomarker of neuro-regeneration in experimental autoimmune encephalomyelitis. MULTIPLE SCLEROSIS. vol. 14, S281-S281.
Gnanapavan S, Carrol C, Candler P et al. (2008) . Paraneoplastic opsoclonus-myoclonus associated with metastatic melanoma and anti-neuroleukin (NLK) antibodies. JOURNAL OF NEUROIMMUNOLOGY. vol. 197, 174-174.
Gnanapavan S, Keir G, Grant D et al. (2008) . A sensitive ELISA method for the detection of human neural cell adhesion molecule (NCam) in cerebrospinal fluid. NEUROLOGY. vol. 70, A338-A338.
Gnanapavan S, Keir G, Mills K et al. (2008) . Reduced cerebrospinal fluid neural cell adhesion molecule (NCam) in neurological disorders, a reflection of the capacity for neuronal regeneration. NEUROLOGY. vol. 70, A338-A338.
Gnanapavan S, Kalmar B, Keir G et al. (2008) . Plasma neurofilament levels as a biomarker of disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. vol. 79, 358-358.
Gnanapavan S, Diemel L, Jackson S et al. (2007) . Demyelination and axonal loss in rat brain aggregate cultures enriched with macrophages following inteferon-gamma induced demyelination. MULTIPLE SCLEROSIS. vol. 13, S258-S258.
Gnanapavan S, Keir G, Grant D et al. (2007) . A sensitive ELISA method for the detection of human Neural Cell Adhesion Molecule (NCAM) in cerebrospinal fluid. JOURNAL OF NEUROCHEMISTRY. vol. 102, 30-30.
Gnanapavan S, Giovannoni G (2007) . Incorporation of other biomarkers. Neurodegeneration in Multiple Sclerosis. Editors: Filippi, M, Rovaris, M, Comi, G, 183-207.
10.1007/978-88-470-0391-0_15
Gnanapavan S, Cockerell OC (2002) . Patient satisfaction in neurology outpatients: Teaching hospital versus district general hospital.J NEUROL NEUROSUR PS vol. 73, (2) 233-233.
Gnanapavan S, Kola B, Bustin SA et al. (2002) . The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.J CLIN ENDOCR METAB vol. 87, (6) 2988-2991.
10.1210/jcem.87.6.8739
Return to top